The fertilization-competent Xenopus egg undergoes a contraction of its cortex towards the apex of the pigmented animal hemisphere within 10 min of fertilization. Evidence suggests that protein kinase C (PKC) is involved in the assembly of this contractile network and we show that PKC is rapidly activated as a result of exposure of oocytes to progesterone. Xenopus oocytes contain at least five different isotypes of PKC. Three actin-binding proteins (i.e. vinculin, talin and ankyrin) appear to play an early role in the assembly of the contractile network and one of the proteins (vinculin) becomes phosphorylated shortly after progesterone treatment as the contractile network is assembling. Our results indicated that progesterone acts through a phospholipase to activate PKC and that PKC participates in the remodeling of the cytoplasmic compartment as the oocyte becomes the egg.
Introduction
The amphibian oocyte/egg system contains several features that make it useful for the identification of mechanisms which regulate assembly of a contractile cytoskeletal network. This is because an actin/myosin network (Meeusen and Cande, 1979; Christensen et al., 1984; Ezzell et al., 1985) assembles in this system with a distinct temporal and spatial pattern (Capco et al., 1992) . Moreover, the network assembles synchronously in stimulated oocytes (Ryabova et al., 1986; Capco et al., 1992) permitting sufficient material for dissection of the cytoplasmic signaling events that regulate assembly and the cellular components that are required for assembly of the contractile network.
The biological function of this contractile network is to contract after fertilization and carry the sperm pronucleus closer to the female pronucleus and consequently to promote syngamy (Elinson, 1977) . This process which occurs in amphibian eggs as a result of fertilization is referred to as a 'cortical contraction'. The amphibian egg also is programmed to rapidly undergo other changes in cytoskeletal organization including those involved with axial organization (Elinson, 1989; Larabell et al., 1996; Rowning et al., 1997) . However, these cytoskeletal assemblies form after fertilization whereas the goal of this investigation is to examine the mechanism(s) which mediates the actin/myosin based cortical contraction that is assembled late in the process of oogenesis.
The fertilization-competent egg is triggered to undergo this cortical contraction by the rise in intracellular free calcium ([Ca 2 + ] i ) (Merriam and Sauterer, 1983; Christensen et al., 1984) which results due to the penetration of the egg by a sperm (Busa and Nuccitelli, 1985; Kubota et al., 1987; Nuccitelli et al., 1988; Bement, 1992) . In contrast, the full grown oocyte cannot undergo this contraction in response to an elevation in [Ca 2 + ] i or after sperm penetration even though such an oocyte can become a fertilization-competent egg within 3-4 h after exposure to the hormone progesterone. Progesterone is the natural stimulus which triggers the oocyte to develop into the egg and is thought to induce a cascade of cytoplasmic signaling events which remodels both the cytoplasmic and nuclear compartments of this cell (Bement and Capco, 1989; Bement, 1992) . The contractile network in the cytoplasm forms in a few hours in response to progesterone and forms in 30-40 min when pharmacological agents that are presumed to activate protein kinase C (PKC) are applied. Recently, PKC has been shown to play a central role in early development in a variety of species (for a review see Gallicano et al., 1997a) . Evidence suggesting a role for PKC in amphibians comes from Stith et al. (1991 Stith et al. ( , 1992 who have shown that metabolism of both diacylglycerol and IP 3 occurs in response to exposure of oocytes to progesterone. These reaction intermediates would be expected to result in a pathway leading to the activation of PKC. More recently, that laboratory reported that PKC becomes active as a result of amphibian egg fertilization (Stith et al., 1997) and their data suggest that phospholipases may have a role in the PKC activation pathway (Stith et al., 1992 (Stith et al., , 1997 . Gallo et al. (1995 Gallo et al. ( , 1996 suggest that the progesterone receptor in amphibians is linked through G-proteins (Kline et al., 1991) to a signaling pathway that may involve phospholipases (Yim et al., 1994) and subsequently activation of PKC.
The rapid development of the ability to contract suggests that the necessary components are present in the cytoplasm and all that is needed is the activation of the correct signaling pathway to induce assembly of a contractile network. We have shown that progesterone induces the ability to contract in a two-step process by employing a bisection bioassay originally developed by Merriam and coworkers (Christensen et al., 1984) . Upon treatment with progesterone, a bisected oocyte will form a contractile ring, which progressively closes at the bisected surface. In order to standardize time points during resumption of meiotic maturation, we employed the descriptor first used by Bement and Capco (1990) , TMM (i.e. Time to complete Meiotic Maturation), which expresses the interval between progesterone application and arrest at meiotic metaphase II in percent. The ability to form a contractile ring initiates after progesterone application (designated 0.1% TMM) and is present through 80% of the process that converts oocytes to fertilization-competent eggs (through 80% TMM). Then, beginning at the 80% time point, the axis of contraction flips 90°resulting in a bisected cell whose cortex then contracts to the apex of the animal hemisphere forming a 'cortical cap' that lifts off the internal cytoplasm. This same type of cortical cap forms when a fertilization-competent egg is bisected (Capco et al., 1992) .
The acquisition of contractile ability in the egg is accompanied by extensive structural remodeling of the oocyte presumably regulated by cytoplasmic signaling events (reviewed by Bement, 1992; Ryabova et al., 1994a) . Consequently, one would anticipate assembly and possibly reorganization of actin, myosin and other actin-binding proteins involved with the acquisition of contractile ability and the reorientation of the axis of contraction. In support of this prediction others have reported the presence of at least four actin-binding proteins in amphibian oocytes and eggs, i.e. vinculin, spectrin, talin and ankyrin (Evans et al., 1990; Ryabova, 1990; Tatone et al., 1993; Ryabova et al., 1994b) . Furthermore, cytoplasmic signaling agents such as PKC have been shown to induce cytoskeletal remodeling in other systems (Aderem, 1992; Downey et al., 1992; . Based on this, we predicted that (1) PKC would be activated through the interaction of progesterone with the oocyte, (2) one or more of these actin-binding proteins would be involved with the development of contractile ability, (3) treatment with progesterone would result in phosphorylation of some or all of the actin-binding proteins and (4) the activation of PKC by progesterone would be mediated by a cascade of cytoplasmic signaling events probably involving phospholipases.
In this study we tested each of these predictions. Our results demonstrate a role for PKC immediately after exposure of an oocyte to progesterone and support a role for phospholipases in the pathway that activates PKC. Moreover, we show that the actin-binding protein, vinculin, is a major player in the development of the ability to contract in this system.
Results

Activation of PKC induces assembly of the contractile network
Treatment of Xenopus oocytes with pharmacological agents such as diacylglycerol (DAG) or phorbol esters (PMA) resulted in the establishment of contractile ability similar to that induced by progesterone, however, the acquisition of ability to contract after exposure to DAG or PMA is much more rapid than that acquired by exposure of oocytes to progesterone (Capco et al., 1992) . The acquisition of this contractile ability is thought to be due to the action of PKC, however, it has not been shown at a biochemical level that PKC is activated after exposure to progesterone, DAG, or PMA. To test if progesterone treatment of oocytes resulted in activation of PKC oocytes were exposed to progesterone and then membrane and cytosol fractions were assayed at increasing time intervals. Several features of the assay selected for detection of phosphorylation by PKC. First, MARCKS peptide (aa. 151-175) was employed as a specific substrate for PKC (Blackshear, 1993; Allen and Aderem, 1995) . This type of peptide substrate is preferred since the complete MARCKS protein or other typical substrates such as myelin basic protein contain phosphorylation sites for numerous kinases. Second, the reaction mixture contained inhibitors of protein kinase A, myosin light chain kinase and tyrosine kinase (see Section 4) to inhibit any spurious phosphorylation reactions. Third, as a control for each fraction the reaction mixture was split and the control aliquot modified to contain two potent inhibitors of PKC, PKC pseudosubstrate (PKCw) and BIM (see Section 4). Thus, comparison of the level of phosphorylation in the experimental lane with that of the control lane would detect any phosphorylation of the MARCKS peptide that was due to a kinase other than PKC.
We measured the amount of the endogenous PKC activity in the membrane and cytosol fractions rather than activating the total PKC in each fraction; this was done by clamping the level of calcium low at each time point the lysate was made which maintains the distribution of PKC activity at the time of homogenization as described previously (Gallicano et al., 1997b) . Once activated PKC no longer requires the presence of calcium (Ashendel, 1985) . In addition to measuring the endogenous PKC activity separately in the membrane and cytosol fraction we also monitored the ratio of signal in membrane/cytosol. The membrane to cytosol ratio was made because when the common isotypes of PKC activate they translocate to the membrane and the change in membrane to cytosol ratio is both a good indicator of the magnitude of the PKC activity increase and a means to standardize samples from different frogs. At 6% TMM (approximately 15 min after exposure to progesterone) there was a 20-fold increase in the level of PKC activity compared to the controls oocytes. After the 6% TMM time point the ratio approximated 1:1 and remained at this level until oocytes meiotically arrested at the white spot (WS) stage representing 100% TMM. At the WS stage the ratio more than doubled. The autoradiograph shown in Fig. 1b illustrates typical results from one experiment for both the membrane and cytosol fractions. The increased signal intensity in the membrane fractions can clearly be noted after progesterone application. In addition, an increased signal intensity in the cytosol also can be noted beginning with the 1 h time point and continuing throughout the remainder of meiotic maturation. This increased activity in the cytosol resulted in the near 1:1 ratio of membrane/cytosol at the 1 h and 3 h time points (Fig. 1a) . The controls in Fig. 1c show duplicate aliquots containing PKC inhibitors. The addition of PKC inhibitors to the reaction mixture blocked phosphorylation of the substrate and indicated that phosphorylation was due to PKC in the experimental lanes. The signal in the cytosol fractions that appeared after PKC was activated may represent protein kinase M (PKM), the catalytic subunit of PKC which is calcium and phospholipid independent and forms as part of the downregulation of PKC (Gallicano et al., 1995) .
To test which isotypes of PKC were present in amphibian eggs we employed a battery of antibodies directed against different PKC isotypes. The a, b I , b II , and g isotypes of PKC were easily detectable in Xenopus, however, detection of other isotypes of PKC required modification of the chemiluminescent detection for maximum sensitivity which allowed detection of the d and z isotypes (Fig. 2) . We If the time required to convert an oocyte to an egg at meiotic metaphase II was 4 h then 2% TMM represents 5 min, 6% TMM represents 15 min, 25% TMM represents 1 h, 75% TMM represents 2 h and 100% TMM represents 4 h. (A) The ratio of signal in the membrane and cytosol fractions obtained from densitometric scans of autoradiographs of PKC assays in control oocytes (0% TMM) and in oocytes at increasing time intervals after exposure to progesterone. Values shown represent the mean ± SEM (n = 3). (B) The autoradiographic results of one experiment summarized in (A). Note that the amount of signal from endogenously active PKC in the membrane fraction increased by 2% TMM and remained high, however, the amount of endogenous activity in the cytosol fraction greatly increased by 25% TMM resulting in a decreased ratio. (C) A control which shows a PKC assay for a parallel aliquot of each lane in (B) that was modified to contain both PKCw and BIM to inhibit any phosphorylation due to PKC. The untreated oocyte is represented by 0% TMM and the egg at meiotic metaphase II is represented by 100% TMM (WS).
could not detect the presence of e, v and i isotypes of PKC.
Agents which disrupt actin/myosin organization inhibit contraction
Treatment with progesterone induces a cytoplasmic signal transduction cascade that initiates reorganization of the cortical cytoskeleton (Capco et al., 1992) . The reorganization is detected in a bioassay when the oocytes are bisected and a contractile ring-like structure that closes in a pursestring fashion at the bisected surface appears. Such a contractile ring-like structure does not appear if untreated oocytes are bisected. Progesterone-treated oocytes are capable of forming a contractile ring within 5 min of treatment and continue to have this ability through 80% of the process of converting an oocyte to a fertilization-competent egg. Abruptly, 80% through this process, the axis of contraction shifts and the progesterone-treated oocyte then forms a cortical cap instead of a contractile ring. This contraction is thought to be dependent on actin and myosin, but it is likely that other actin-binding proteins have a role, both because of the rapid establishment of the contractile ability and because later the axis of contraction shifts when assayed by bisection. Consequently, we predicted that if we disrupted the actin/myosin organization or the organization of actin-binding proteins we would block the establishment of contractility. In support of this prediction antibodies to actin or myosin independently were capable of inhibiting formation of the contractile ring when microinjected into oocytes which were subsequently treated with progesterone and bisected (Fig. 3) . To control for non-specific effects of antibodies and for the involvement of tubulin in contractility, we microinjected antibodies to tubulin and showed that they were largely ineffective in blocking formation and closure of the contractile ring (Fig. 3) . All antibodies injected were tested for their ability to bind Xenopus oocyte proteins of the correct molecular weight by Western analysis in preliminary experiments (data not shown). As a further control to demonstrate that actin was needed to induce formation of a contractile ring, oocytes were microinjected with DNase I which binds to the fast growing end of actin filaments and promotes filament disassembly (Mannherz et al., 1980; Sanger et al., 1990) . Such oocytes were then treated with progesterone and bisected. Microinjection of 250 ng of DNase I into an oocyte completely obliterated the ability of a contractile ring to form at the bisected surface (Fig. 3) .
Microinjection of antibodies to some actin-binding proteins blocked the ability to form a contractile ring
Next we tested the inhibitory ability of antibodies to actin-binding proteins reported to exist in Xenopus oocytes, that is antibodies to vinculin, talin, spectrin and ankyrin (Evans et al., 1990; Tatone et al., 1993; Ryabova et al., 1994b) . Microinjection of antibodies to vinculin completely obliterated the ability of a contractile ring to form in response to progesterone application followed by bisection (Fig. 4a ). Antibodies to talin and ankyrin were more than 90 and 60% effective in blocking contractile ring formation, respectively (Fig. 4a) . In contrast, antibodies to spectrin were only 18% effective in blocking contractile ring forming ability in bisected oocytes after treatment with progesterone. As controls the antibodies were denatured with heat and then microinjected (data shown for heat denatured antivinculin antibody). Injection of heat denatured antibodies had no effect on the formation of a contractile ring.
The ability to form a contractile ring as a result of oocyte bisection is the first of two contractile events as the oocyte is converted to the fertilization-competent egg. The second contractile event occurs 80% through resumption of meiotic maturation when the axis of contraction is shifted by 90°a nd the bisected oocyte forms a cortical cap (Capco et al., 1992) . Analysis of inhibitory effects of antibodies to actinbinding proteins is considerably more difficult to test at this time point in progesterone-treated oocytes for several reasons. Firstly, oocytes begin to develop asynchronously as they progress through the progesterone-induced resumption of meiosis. Secondly, at this point in the progesteroneinduced reorganization, the oocyte has considerably more turgor and microinjection results in an extensive cytoplasmic exudate from the microinjection site. Thirdly, if oocytes Fig. 2 . Western analysis for the isotypes of PKC present in Xenopus oocytes. Each isotype is shown next to a positive control lane (a is alpha, b I is beta I, b II is beta II, g is gamma, d is delta and y is zeta isotypes). Positive control lanes are rat brain lysates supplied by Transduction Laboratories. The experiment was repeated three times. Fig. 3 . Effect of agents which disrupt actin or myosin organization on the ability to form contractile rings after a treated Xenopus oocyte is bisected. In separate experiments Xenopus oocytes were microinjected with antibodies to actin and myosin or were microinjected with DNase I and then treated with progesterone. Controls show the effects of bisection after treatment with progesterone and bisection without progesterone treatment. Microinjection of anti-tubulin antibody was employed as an additional control to demonstrate the effects of an unrelated immunoglobulin. Values shown represent the mean ± SEM (n = 3).
were injected with antibodies to actin-binding proteins prior to treatment with progesterone (which would allow the microinjection site to heal prior to the development of turgor) then at least 3 h would be required to reach 80% through the process and the microinjected antibodies might be depleted by proteolysis. To circumvent this problem, we injected oocytes with the appropriate antibodies and treated them with PMA. Oocytes subjected to this treatment have been shown to exhibit this shift in the axis of contraction 30-35 min after treatment. Under these conditions only antibodies directed against vinculin are capable of blocking the contractile event (Fig. 4b) . Antibodies to talin and ankyrin were no longer effective in inhibiting contraction. When the antibody to vinculin was denatured prior to microinjection it could no longer block the contractile event.
Vinculin becomes phosphorylated after progesterone treatment
Results in the previous sections suggested that actin-binding proteins, particularly vinculin, are important in regulating the ability to contract in the oocyte/egg system and that progesterone treatment of oocytes activates PKC. Thus, it seemed reasonable to predict that treatment with progesterone would result in phosphorylation of at least one actinbinding protein. To test this we microinjected radiolabeled ATP into oocytes and prepared lysates at increasing time intervals throughout the resumption of meiosis. For each lysate a sequence of immunopurifications were conducted employing antibodies in the following order: anti-spectrin, anti-ankyrin, anti-talin and anti-vinculin. Vinculin was chosen as the last actin-binding protein to be immunopurified since we observed it to be phosphorylated in preliminary experiments. This sequence of isolation provided an internal control for the action of endogenous phosphatases which might somehow circumvent the phosphatase inhibitors in the lysate. Phosphorylation of spectrin, ankyrin and talin was not detectable in our experiments. In contrast, we detected phosphorylation of vinculin 30 min after progesterone treatment (Fig. 5) in the same lysates.
Progesterone induces a cascade of signaling events
Binding of progesterone to the oocyte receptor initiates a number of changes that influence the cytoplasmic and nuclear compartments Capco et al., 1992) . As noted in Section 1 we hypothesized that cytoskeletal reorganization including ability to form a contractile ring is mediated by the activation of a phospholipase and subsequent activation of PKC. To test this we injected oocytes with either phospholipase C (in separate experi- Antibodies to vinculin obliterated the ability to form a contractile ring, but if the antibodies were heat denatured prior to microinjection the ability to form a contractile ring was unaffected. Antibodies to tubulin were also microinjected as a control and had no effect on the ability to form a contractile ring. (B) Oocytes microinjected as indicated and then treated with PMA to induce cortical contraction. Antibodies to vinculin obliterated the ability to undergo cortical contraction, but if the antibodies were heat denatured (H.D.) prior to microinjection the ability to contract was restored. Fig. 5 . Phosphorylation of vinculin after oocytes are exposed to progesterone. Oocytes were microinjected with [g-32 P]ATP and either treated with progesterone (P) or left untreated and allowed to incubate for the same time interval as those oocytes treated with progesterone to compare the basal level of phosphorylation (C). Cell lysates were prepared at each time interval and the following actin-binding proteins were sequentially immunopurified in the presence of phosphatase inhibitors: spectrin, ankyrin, talin and vinculin. After gel electrophoresis phosphorylation of spectrin, ankyrin and talin could not be detected (however, Western analysis demonstrated the presence of each of the actin-binding proteins (data not shown)), but phosphorylation of vinculin was evident 30 min after treatment with progesterone. ments as phosphatidylinositol-specific or phosphatidylcholine-specific PLC with equivalent results) or with the constitutively active form of PKC which is referred to as PKM Takai et al., 1977; Kishimoto et al., 1983) and bisected the oocytes without exposure to progesterone (Fig. 6a,b) . The positive and negative controls (i.e. the ability to form a contractile ring with and without exposure to progesterone) are shown for comparison. In replicate experiments microinjection of PLC induced contractile rings after bisection in almost 100% of treated samples. If the PLC was heat denatured prior to injection it lost all ability to induce a contractile ring. Similarly, microinjection of the constitutively active kinase, PKM, induced contractile rings in approximately 70% of the oocytes. If the PKM was denatured by heat treatment prior to microinjection the ability to induce a contractile ring was obliterated. The data show that microinjection of PLC and PKM is capable of inducing contractile ring formation. However, these data do not demonstrate that the pathway initiated by progesterone acted through these agents.
To test if progesterone acts through PKC and/or PLC we separately blocked the presumed action of one of these signaling agents, treated the oocytes with progesterone and bisected the oocytes to test whether a contractile ring would form. Three different treatments were used to block the presumed PKC action. In separate experiments oocytes were microinjected with (1) antibody to the catalytic subunit of PKC in an attempt to block the biological activity of PKC, (2) PKCw, a highly specific peptide inhibitor of PKC and (3) BIM, a highly specific pharmacological inhibitor of PKC (Fig. 7a) . Then the oocytes were exposed to progesterone. In all three types of treatments agents that blocked PKC activity also blocked the ability to form a contractile ring after treatment with progesterone. Similarly we blocked the action of PLC by injection of antibodies to PLC (Fig. 7b) . This treatment also blocked the ability to form a contractile ring after treatment with progesterone, however, if the antibody was denatured prior to microinjection it could not block the formation of a contractile ring. Both types of results supported the hypothesis that PLC and PKC are involved in the pathway triggered by progesterone that leads to the formation of a contractile ring.
To establish the order of action between PLC and PKC in separate experiments we sequentially inhibited one signal while activating the other (Fig. 8) . When oocytes were first microinjected with the same concentration of anti-PLC antibody used in Fig. 7b to block contractile ring formation when challenged with progesterone and then microinjected with the same concentration of the constitutively actively PKC (i.e. PKM) employed in Fig. 6b they exhibited the ability to form a contractile ring almost at the same level as the progesterone controls. In contrast, when PKCw was first microinjected at the same concentration used in Fig. 7a to block contractile ring formation when challenged with progesterone and then microinjected with PLC at the same concentration as employed in Fig. 6a the ability to form a contractile ring was greatly reduced. These results support the hypothesis that binding of progesterone to its receptor leads to activation of PLC and later PKC becomes active.
Discussion
The actin/myosin based contraction of the cortex of the amphibian egg results from a change in the assembly and organization of the cortical cytoskeleton. These changes occur in an orderly fashion in response to the resumption of meiotic maturation induced by the natural triggering agent of these oocytes, progesterone. The ability to undergo contraction of the cortex to the apex of the animal hemisphere is a two-step process that can be assayed for using a bisection bioassay . In the initial step the cortex acquires actin/myosin dependent contractile ability to form a contractile ring at the bisected surface Capco et al., 1992) and in the second step the axis of contraction is shifted by 90°so that the direction of contraction becomes oriented towards the apex of the animal hemisphere (Capco et al., 1992; Ryabova et al., 1994a) . We have used this system to examine the regulation and assembly of the contractile network. Based on results from treatments with pharmacological agents several reports suggest that PKC is involved with the resumption of meiotic maturation triggered by progesterone (Bement and Capco, 1989; Grandin and Charbonneau, 1991; Stith et al., 1991) . However, these studies did not provide biochemical evidence to confirm that PKC activity had changed. Recently, Stith et al. (1997) have shown a change in PKC activity at the time of fertilization in Xenopus and in the mammalian system we provided biochemical evidence to demonstrate that PKC becomes active as a result of fertilization (Gallicano et al., 1997b) . In this study we show that PKC becomes active in Xenopus oocytes immediately after they are exposed to progesterone. This supports the position that PKC is a major signaling agent involved in early development in a variety of species (Gallicano et al., 1997a) . Stith et al. (1997) tested for the presence of both the a and b isotypes of PKC and could detect both in fertilization-competent Xenopus eggs. In this study we tested for several different isotypes of PKC and in oocytes we could identify the a, b I , b II and g isotypes and at lower levels the d and z isotypes.
Results from our investigation indicate that actin-binding proteins reported to be present in Xenopus oocytes appear to have a role in the ability of the oocyte cortex to contract. When antibodies to vinculin, talin, ankyrin and spectrin are separately microinjected into Xenopus oocytes and the oocytes are treated with progesterone, antibodies to the first three of these actin-binding proteins are effective in blocking the formation of a contractile ring in our bioassays with antibodies to vinculin being most effective. Only antibodies to vinculin blocked formation of cortical caps measured in the bioassay. When the contractile ring closes and when the intact oocyte contracts the cell's plasma membrane also moves suggesting a link between the actin/myosin network and the plasma membrane. Vinculin's ability to link actin to cell membranes (Burn and Burger, 1986; Niggli et al., 1986 ) makes it well suited for this role. Finally, our data indicate that progesterone acts through phospholipase C to activate PKC.
Some reports suggest that PIP 2 hydrolysis has a role in the progesterone-induced pathway (Stith et al., 1991) and also that G-proteins may play some role (Gallo et al., 1995) . In addition, some studies suggest that it is not hydrolysis of PIP 2 , but rather hydrolysis of another phospholipid such as phosphatidylcholine (PC) by a specific phospholipase (Carnero and Lacal, 1993) through which progesterone acts. Further support for a PC-specific pathway in Xenopus comes from the recent report of Stith et al. (1997) who show that at fertilization the magnitude of the DAG increase would be best explained by hydrolysis of PC and not PIP 2 . Our results are consistent with these models since we can demonstrate a role for phospholipases and because G-proteins could activate phospholipases. We have employed both PC-specific and a PI-specific phospholipase in our experiments and found no significant difference between the outcomes. Both phospholipase mediated pathways could exist, but one might be the preferred route through which progesterone acts. Carnero and Lacal (1993) suggested that some phospholipase activity may be independent of PKC as it acts on the nuclear compartment. However, with regard to the cytoplasmic compartment we report here that inhibition of PKC activity blocks the ability of the Fig. 8 . PKC acts downstream of PLC to induce contractile rings. Oocytes were microinjected with an inhibitor to one signaling agent (either PKCw or anti-PLC antibodies) shown to be effective in Fig. 7 and subsequently microinjected with the other agent to activate PKC or PLC at a concentration shown to be effective in Fig. 7 . Oocytes were bisected and assayed for the ability to form a contractile ring. Blocking PKC activity greatly reduced the ability to form contractile rings in response to microinjected PLC, while blocking PLC activity had little effect when the catalytic subunit of PKC (PKM) was microinjected. Values shown represent the mean ± SEM (n = 3).
oocyte to contract even when phospholipase activity is increased.
Progesterone induces remodeling in both the cytoplasmic and nuclear compartments resulting in the change in function of one cell type, the oocyte, to the function of another cell type, the fertilization-competent egg. Current results suggest that PKC (activated by progesterone treatment) acts on the cytoplasmic compartment while parallel pathways initiated by progesterone act on the nuclear compartment. How does PKC, a kinase whose common isotypes are membrane dependent, act on the entire cytoplasmic compartment? One possibility is that a novel membrane-independent PKC may be acting here. Alternatively, the model shown to exist in mammalian eggs at fertilization may also act in amphibian oocytes. In mammalian eggs we have shown that PKC and PKM (the catalytic subunit of PKC) act with both temporal and spatial precision (Gallicano et al., 1995) . PKC becomes active at the plasma membrane of the mammalian egg as a response to fertilization and then as part of the downregulation of PKC (Jaken, 1990; Hashimoto and Yamamura, 1991) PKM is formed by cleavage of the catalytic subunit from the membrane/pseudosubstrate domain. Once cleaved PKM is both calcium and membrane independent, diffuses into the cell interior and phosphorylates internal substrates (Gallicano et al., 1995) . This provides for an orderly remodeling of the cell with both temporal and spatial precision.
PKC activation in somatic cells is known to induce remodeling of cell organization and to act on specific cytoskeletal components including vinculin (Aderem, 1992; Tang et al., 1993; Timar et al., 1993) and our data support such a role in the oocyte/egg system. In the establishment of the initial contractile event detectable in the bisected oocyte vinculin, ankyrin and talin appear to have a role as determined by assaying for inhibitory effects of microinjected antibodies to these proteins. However, after the axis of contraction shifts to the apex of the animal hemisphere only antibodies to vinculin remain capable of blocking the cortical cap contraction suggesting that in the reorganized cortical cytoskeleton talin and ankyrin have a reduced role. The cortical contraction precedes a series of contractile events in the fertilized egg, that is the formation of cleavage furrows accompanying each of the embryonic cell divisions. Few studies have examined the signaling events which regulate formation of the cytokinetic ring in cleavage furrows. In such a system the contractile network forms rapidly and data indicating a rise in [Ca 2 + ] i accompanying the metaphase-anaphase transition (Ratan et al., 1988; Hepler and Callaham, 1987) hint at a role for a calcium-dependent activation of PKC. The rapid assembly of the contractile network of the contractile ring may be regulated by a mechanism similar to the cortical contraction. The model of PKC/PKM activation, and subsequent phosphorylation of actin-binding proteins such as vinculin, developed from this study may serve as a useful model for the analysis of the furrow.
Experimental procedures
Oocyte procurement
Adult female Xenopus laevis were purchased from Nasco Biological Supply (Fort Atkinson, WI) and maintained on a 14 h light/10 h dark cycle in tanks containing 10% Holtfreter's solution which was continuously recirculated and filtered. Fresh solution was added at a rate which replaced 50% of the tank volume each week. Ovarian fragments were surgically removed from the ventral body wall of females anesthetized by hypothermia. Ovarian fragments were placed in 1× O-R2 medium (Wallace et al., 1973) (82.5 mM NaCl, 2.5 mM KCl, 1 mM Na 2 HPO 4 , 3.8 mM NaOH, 1 mM MgCl 2 , 1 mM CaCl 2 , 5 mM HEPES (pH 7.4)). Follicle cells were removed by incubating ovary fragments at room temperature in a plastic petri dish for 1 h in 1× O-R2 made 1% with collagenase (type I, Sigma, St. Louis, MO). Subsequently, oocytes and ovary fragments were washed thoroughly in 1× O-R2, incubated for 1 h at 18°C, placed in new plastic petri plates, to which the follicle cells adhered, and then rolled out of the follicle cell sheath with forceps . Oocytes with a diameter of 1.2-1.4 mm were used as full-grown oocytes.
Standardization of the developmental time course
Since there is variability in the amount of time it takes clutches of oocytes from different female frogs to progress through the resumption of meiosis after the addition of progesterone, we standardized the time course by adjusting the TMM in control experiments for each clutch of oocytes (i.e. the appearance of a white spot at the apex of the animal hemisphere) as the 100% time interval (100% TMM) as has been described previously (Bement and Capco, 1989) . In this way each time point from different female frogs could be expressed as a percentage of the time to complete meiotic maturation (i.e. white spot) and a clutch of oocytes that matured in 4 h could be compared with a different clutch that matured in 6 h. Experiments were conducted only when controls demonstrated that ≥80% of the oocytes treated with progesterone acquired a white spot at the apex of the animal hemisphere denoting completion of meiosis. Similarly, experiments were conducted only when ≥80% of the oocytes responded appropriately in the positive and negative controls for the bisection assay (see Section 4.3).
Bioassay for development of contractile ability
Oocytes were bisected between animal and vegetal hemispheres, as originally reported by Christensen et al. (1984) and modified by Bement and Capco (1991) . Hemispheres, prepared from whole oocytes using Iris spring microscissors, were placed bisected surface down in petri plates containing 1× O-R2, unless otherwise described. After bisection, treated oocytes expressed one of three struc-tural changes, i.e. the bisected surface of the hemisphere closed in a purse-string fashion (contractile ring), the cortex of the bisected oocyte contracted off of the internal cytoplasm towards the apex of the hemisphere (cortical cap) or there was no contractility of the hemisphere as occurs in otherwise untreated oocytes (Capco et al., 1992) .
Controls for the bioassay were performed to test each clutch of oocytes before experiments were conducted. For experiments involving contractile ring forming ability of bisected oocytes, two control experiments were performed. First, as a positive control, sham injected oocytes (injected with 50 nl of PBS) were allowed to recover for 15 min, exposed to progesterone (30 min, 2 mg/ml in 1× OR-2) and bisected. In this case, a successful positive control was the formation of contractile rings in greater than 80% of treated oocytes. Second, as a negative control, sham injected oocytes (50 nl PBS) were allowed to recover for 15 min, incubated in media without progesterone (30 min) and bisected. A successful negative control experiment in this case was the absence of contractile ring forming ability in the bisected hemisphere. Control experiments for cortical cap forming ability also had positive and negative controls. In positive controls sham injected oocytes (as above) were treated in media containing 100 nM PMA for 5 min and then bisected 40 min later. As negative controls sham injected oocytes were bisected after 40 min in media without PMA treatment. Experiments were conducted only if oocytes treated with PMA displayed cortical cap formation after bisection of the oocytes while untreated oocytes were unaffected. A total of 10 oocytes from three different frogs were used for each control and experimental procedure. Results shown are the mean ± standard error of the mean (SEM), where n = 3.
Oocyte injection
Microinjection
Injection needles were prepared by using 3.5-inch long capillary tubes with an outside diameter of 1 mm (Drummond Scientific, Broomall, PA). Capillary tubes were pulled on a vertical micropipette puller (#l PB-2, Narishige Instrument Lab, Japan) and selected for a tip diameter of 10 mm. Oocytes were injected using the Drummond Nanoinject (#3-00-203-X) micropipette system held in a micromanipulator (#M152, Narishige).
Immediately prior to injection, oocytes were placed in a plastic petri plate containing 1.5× O-R2. The microinjection needle was positioned at a 45°angle above the hemisphere of an oocyte. Each oocyte was microinjected at its center, avoiding the nucleus. Oocytes were then transferred to a plastic petri plate containing 1× O-R2 and allowed to recover for 15 min. 
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PKC antagonists
To inhibit PKC activity, oocytes were injected with 107.6 ng PKC pseudosubstrate (denoted PKCw) (BioMol, Plymouth Meeting, PA, , 5 pg anti-PKC antibodies (Upstate Biotechnology, Lake Placid, NY, cat #05-154) or bisindolylmaleimide (BIM) (#203290-S Calbiochem) to an intracellular concentration of 2 mM assuming a total aqueous volume of 400 nl per oocyte.
Antibodies
Antibodies that were to be injected into oocytes were dialyzed against intracellular buffer (ICB) (100 mM KCl, 5 mM MgCl 2 , 3 mM EGTA, 20 mM HEPES (pH 6.8)) prior to injection. In some cases IgGs were purified prior to injection using an IgG purification kit (Pierce, Immunopure, cat. #44902G). Preliminary experiments were conducted to assure that the antibodies were capable of recognizing the appropriate Xenopus oocyte proteins by Western analysis. The following antibodies were employed for immunopurification, microinjection and Western analysis: anti-actin antibody (Boehringer Mannheim, Indianapolis, IN, clone C4, cat. #1378996), anti-myosin antibody (Sigma, St. Louis, MO, cat. #M7648), anti-vinculin antibody (Sigma, clone VIN-11-5, cat. #1174843), anti-tubulin antibody (Sigma, clone #DM1A, cat.#T9026), anti-spectrin (ICN Biomedicals, Costa Mesa, CA, cat. #65-798), anti-talin antibody (Sigma, clone 8d4, cat. #T-3287), anti-ankyrin antibody (Calbiochem, San Diego, CA, cat. #176890), antiphospholipase C gamma-1 (Upstate Biotechnology, cat. #06-159), protein kinase C sampler kit (Transduction Laboratories, cat. #585080) and anti-b I and anti-b II PKC antibodies (BioMol, respectively) . When used for microinjection after dialysis or purification the volume containing the antibody was adjusted to be identical to volume of the antibody when purchased. Antibodies were injected in a 50 nl bolus with the Drummond microinjector. After microinjection oocytes were allowed to recover from the trauma of microinjection for 1 h before any further treatment and this recovery period also permitted time for the antibody to diffuse throughout the oocyte. If an antibody appeared ineffective in blocking contractile ring formation two additional controls were imposed. Firstly, additional boluses of antibody were injected into the oocyte to introduce more antibody and secondly, oocytes were permitted longer recovery times (up to 24 h) to permit more time for diffusion of the antibody and for binding of the antibody to the antigen. Antibodies to actin required a double injection to be effective.
DNase I
DNase I (250 ng) (Sigma, DN-EP) in ICB was microinjected into oocytes to disrupt actin filaments. For these experiments it was necessary to permit oocytes to incubate for 1 h after microinjection.
Phospholipase
Two types of phospholipase C were employed in these experiments. Oocytes were injected with either 0.075 IUs of phosphatidylinositol-specific phospholipase C (Boehringer Mannheim, cat. #1143069) or 0.2 IUs phosphatidylcholinespecific phospholipase C (Boehringer Mannheim, cat. #691950).
Treatment with progesterone and phorbol esters
Defolliculated oocytes were treated with either progesterone (2 mg/ml in 1× O-R2, Sigma) or phorbol 12-myristate 13-acetate (PMA) (100 nM in 1× O-R2, Sigma) and then assayed at increasing time intervals after treatment. Working concentrations of both progesterone and PMA were made fresh prior to each experiment, kept at 4°C and used for a maximum of 4 h. Oocytes were treated with progesterone and experimental groups were assayed at 0, 2, 6, 25, 75 and 100% time to meiotic maturation. A total of 10 oocytes were treated per time point with three independent experiments averaged for each time point.
Immunopurification
Oocytes were microinjected with radiolabeled ATP and separated into an experimental group that was treated with progesterone or an untreated control group (20 oocytes/per group) and transferred into 1.5 ml eppendorf tubes. Excess medium was removed and 50 ml of immunopurification (IP)/SDS buffer (0.15 M NaCl, 0.001 M EDTA, 0.01 M Trizma base (pH 7.5), 2% SDS, 240 mM b-glycerophosphate and 120 mM p-nitrophenyl phosphate) was added. Oocytes were homogenized in IP/SDS and then diluted 1:20 in IP/NP40 buffer (0.15 M NaCl, 0.001 M EDTA, 0.01 M Trizma base (pH 7.5), 0.65% NP40, 50 mg/ml AEBSF, 240 mM b-glycerophosphate and 120 mM p-nitrophenyl phosphate). Antibody to talin was added and incubated at 4°C for 24 h on a rocker. The next day, 50 ml of washed Pansorban cells (Calbiochem, cat. #507861) was added, for a total volume of 100 ml, and incubated with rocking for 1 h. The mixture was centrifuged to pellet the Pansorban cells and associated antigen-antibody complex. The supernatant (SP-1) contained other actin-binding proteins that were potentially phosphorylated and was removed. SP-1 was then consecutively challenged with antibodies to spectrin, ankyrin, talin and vinculin and immunopurified in that order. The pellet was washed three times with IP/NP40 buffer and the first two washes were added back to the supernatant fraction (SP-1). The pellet was resuspended in 7 ml 2× sample buffer. The mixture was then centrifuged pelleting both the yolk and Pansorban cells while the supernatant containing the purified proteins was subjected to SDS-PAGE on 10% gels. Phosphoproteins were detected following autoradiography. Immunopurified lysate from untreated control oocytes incubated with radiolabeled ATP for the same time intervals as the progesterone treated oocytes were run in adjacent lanes to allow for comparison with basal levels of phosphorylation.
Lysates for PKC assay
Oocytes were treated with progesterone and separated into membrane and cytosol fractions at increasing time intervals after treatment. Twenty oocytes were used for each time point. Oocytes were washed twice in 20 mM KCl, 5 mM MgCl 2 , 10 mM EGTA and 20 mM HEPES (pH 7.6) and gently packed into the bottom of a tube. Supernatant was removed and 20 ml of homogenization buffer was added (100 mM KCl, 5 mM MgCl 2 , 10 mM EGTA, 20 mM HEPES (pH 7.6), 32 mg/ml each of pepstatin, aprotinin, chymostatin, leupeptin and trypsin-chymotrypsin inhibitor, 240 mM b-glycerophosphate and 120 mM p-nitrophenyl phosphate) and the oocytes were homogenized. Lysate was separated by centrifugation in a Beckman Airfuge at 30 psi for 20 min to separate the lysate into three layers (membrane at the top, cytosol in the middle and yolk at the bottom). Membrane and cytosol fractions are removed with a micropipette and placed in a 2.5 cm long microfuge tube that holds a 0.25 ml volume. This is spun in a Sorval microfuge for 10 min at maximum speed to again separate the membrane and cytosol; any yolk contaminating this fraction will appear at the bottom of the tube. A 25 gauge needle attached to a syringe is inserted bevel up at the bottom of the cytosol fraction, but above any contaminating yolk, and the cytosol fraction is removed; the membrane fraction will cling to the walls of the microfuge tube. Some membrane may contaminate the cytosol fraction and can be removed by a subsequent centrifugation to partition the contaminating membrane to the top of the supernatant and can be removed by touching the lipid with a pipette tip precooled in liquid nitrogen. This membrane is combined with the remaining membrane fraction. To remove the membrane fraction from the 2.5 cm long tube it is seated in a larger diameter microfuge tube with the hole made by the 25 gauge needle oriented along the centripetal axis and 1.5 ml of 20% NP40 is added to the tube above the membrane fraction (the volume of NP40 added here should be adjusted to equalize the volume with the cytosol fraction) and centrifuged for 10 min at room temperature. This procedure solubilizes the membrane and collects it in the outer tube while leaving any contaminating yolk behind in the 2.5 cm long tube.
The cytosol and membrane fractions are assayed separately for PKC activity since the common isotypes of PKC translocate to the membrane when activated. For this reason PKC activity is often expressed as the ratio of signal between membrane/cytosol. It is important to note that the fractionation procedure described in the preceding paragraph and the PKC assay described here is designed to measure the endogenous PKC activity in the fractions and for this reason calcium levels are clamped low with the calcium chelator EGTA. The PKC assay reaction is performed in 10 ml. The reaction mixture is composed of 100 mM KCl, 5 mM MgCl 2 , 10 mM EGTA, 20 mM HEPES (pH 7.6), 240 mM b-glycerophosphate, 120 mM p-nitrophenyl phosphate, 1 mg/ml protease inhibitor cocktail (as described above), 5 mg of MARCKS peptide (aa. 151-175), the following kinase inhibitors (2.2 mM PKI, 10 mM ML-9, 75 mM Genestein), 5 mCi [g-32 P]ATP (S.A. 6000 Ci/mM, Amersham, Redivue) and 1.5 ml of either the cytosol or membrane fraction. The kinase assay was reacted for 30 min at 37°C and stopped by addition of 2× concentrated SDS-sample buffer. As controls, a duplicate aliquot of each cytosol or membrane fraction was reacted identically except that in addition to the other kinase inhibitors that were present in the reaction mixture PKCw and BIM were added at final concentrations of 200 and 2 mM, respectively, and preincubated for 15 min at room temperature before addition of the substrate and [g-32 P]ATP. In controls, PKCw and BIM should obliterate PKC phosphorylation of MARCKS peptide substrate. Any signal from such a reaction would be from a kinase other than PKC. Proteins were separated by electrophoresis on 15% SDS polyacrylamide gels and viewed after exposure of autoradiography film.
Western analysis
The Pierce chemiluminescent detection kit (Pierce Chemical, Rockford, IL, cat. #34080L) was employed for detection of PKC isotypes. When detection was to be conducted at enhanced sensitivity we employed Pierce's Ultra sensitive detection kit (cat. #37078L), increased the concentration of primary antibody and also increased the time of nitrocellulose membrane incubation in chemiluminescent substrate in order to increase sensitivity. The equivalent of one Xenopus oocyte was applied per lane and a control sample containing the appropriate PKC isotype was applied in the adjacent lane. Antibodies to PKC b I and b II (BioMol) detected the two isotypes, while an anti-PKC b antibody supplied by Transduction Laboratories gave negative results.
